Drug giant Novartis sees higher sales

Novartis expects higher sales and profitability this year, lifted by its broad range of drugs, and minimal disruption to its supply chain from the coronavirus outbreak in China.

The Swiss pharmaceutical giant said in October it plans to shed 320 jobs, more than half the workforce, at its Cork campus over the next three years.